Displaying items by tag: department of medicine

A detailed mechanistic study unravels how the bacterial endotoxin LPS prevents or promotes allergic disease.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

This revitalization kick-off event follows ribbon-cuttings held in two other Live HealthSmart Alabama demonstration communities, Titusville and Kingston, earlier this year. 

UAB’s Know Overdose Initiative seeks to educate, identify and prescribe Naloxone for individuals who have been identified as high risk for overdose.

At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.

Kirklin received this award for his dedication to advancing the science and treatment of children through the journey of heart transplantation.

COERE awarded $500,000 to provide funds for research supplements to early-career physician-scientists whose research has been impacted by COVID-19.

Nearly 100,000 people in the United States have AE-IPF, and approximately 30,000 to 40,000 new cases are found each year.

The study concluded that participants were hesitant to receive the COVID-19 vaccine due to mistrust, fear and lack of information.

The infusion therapy can help shrink tumors that are otherwise inoperable.